400mcg Sublingual Misoprostol as First Line Treatment
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
Women presenting with incomplete abortion and eligible for treatment with misoprostol were
offered 400mcg sublingual misoprostol for treatment. Based on existing literature, the study
hypothesises that women can successfully be treated with misoprostol alone as first line
treatment.